弹性蛋白酶来源于人类白血球
Elastase, Human leukocytes 是一种丝氨酸蛋白酶，存在于中性粒细胞的亲氮颗粒中。Elastase, Human leukocytes 潜在底物包括细胞外基质的几乎所有成分，以及凝血因子、补体、免疫球蛋白和细胞因子等多种蛋白质，有强大的蛋白质水解功能，参与炎症组织损伤的发病机制。
托拉菌素A (标准品)
Tulathromycin A (Standard)是 Tulathromycin A 的分析标准品。本产品用于研究及分析应用。Tulathromycin A (Tulathromycin) 是一种大环内酯类抗生素 (antibiotic)，通过靶向细菌核糖体抑制蛋白质合成 (IC50=0.26 μM)。Tulathromycin A 用于研究牛和猪的呼吸道疾病。具有免疫调节作用。
Human MOG-specifying DNA 位于 6 号染色体的人类白细胞抗原 (HLA) 基因位点内。Human MOG-specifying DNA 仅在中枢神经系统 (CNS) 的髓鞘和少突胶质细胞突起表面表达，并在 ODC 中具有独特的甲基化模式。Human MOG-specifying DNA 可用于多发性硬化症 (MS) 等炎症性脱髓鞘疾病的研究。
Hyaluronan-binding peptide, biotin labeled TFA 是一种有生物活性的肽。(该肽是一种通过 C 端 GGGSK 连接体生物素化的透明质酸结合肽。透明质酸 (HA) 是一种在细胞外基质和细胞表面表达的非硫酸化糖胺聚糖。 HA 在受精、胚胎发育、伤口愈合、血管生成、白细胞运输至发炎组织和癌症转移中发挥作用。该肽已被证明可以阻断 HA 与 CD44 受体的结合并抑制 T 细胞增殖。)
CD19 CAR circRNA 可以表达 CD19 car 蛋白，并且可用于嵌合抗原受体 T 细胞免疫疗法 (CAR-CD19)。 CD19 car 是一种嵌合抗原受体。其中 CD19 是 B 细胞表达的一种 CD 分子 (即白细胞分化抗原)，参与 B 细胞增殖、分化、活化及抗体产生的重要膜抗原，还可促进 BCR 的信号转导。
Protein A (SPA) 是一种存在于细菌表面并可自由分泌到细胞外环境中的免疫球蛋白 (Ig) 结合蛋白。Protein A 通过结合抗体的 Fc 区和 B 细胞受体的 Fab 区，从而阻断调理吞噬作用并在体外导致 B 细胞凋亡 (apoptosis)。Protein A 可与 IgG 形成毒性免疫复合物，进而诱导白细胞坏死。Protein A 有助于金黄色葡萄球菌的毒力表达。Protein A 在经 IgG 预处理的小鼠模型中引发过敏反应。Protein A 可用于免疫系统疾病的相关的研究。
人纤维蛋白原
Fibrinogen from human plasma 是一种在肝脏中合成的、糖基化的血浆蛋白。Fibrinogen from human plasma 是血液中浓度最高的凝血因子之一，是凝血级联反应的关键终点。Fibrinogen from human plasma 是纤维蛋白的前体蛋白，可形成血凝块。Fibrinogen from human plasma 作为一种主要的急性时相反应蛋白，在炎症、感染、创伤等刺激下，其在血浆中的浓度会迅速升高并通过整合素受体与多种细胞 (如血小板、白细胞、成纤维细胞) 相互作用，参与炎症反应、伤口愈合和组织重塑。
Human CCR4 mRNA编码人类CC基序趋化因子受体4 (CCR4) 蛋白，该蛋白属于G蛋白偶联受体家族。CCR4是CC趋化因子（MIP-1、RANTES、TARC和MCP-1）的受体。趋化因子是一类结构相关的小分子多肽，能够调节各种白细胞的细胞运输。趋化因子还在免疫系统的发育、稳态和功能中发挥重要作用，并对中枢神经系统细胞以及参与血管生成或血管停滞的内皮细胞产生影响。
人纤维蛋白原
Fibrinogen from human plasma 是一种在肝脏中合成的、糖基化的血浆蛋白。Fibrinogen from human plasma 是血液中浓度最高的凝血因子之一，是凝血级联反应的关键终点。Fibrinogen from human plasma 是纤维蛋白的前体蛋白，可形成血凝块。Fibrinogen from human plasma 作为一种主要的急性时相反应蛋白，在炎症、感染、创伤等刺激下，其在血浆中的浓度会迅速升高并通过整合素受体与多种细胞 (如血小板、白细胞、成纤维细胞) 相互作用，参与炎症反应、伤口愈合和组织重塑。
Protein A (SPA) 是一种存在于细菌表面并可自由分泌到细胞外环境中的免疫球蛋白 (Ig) 结合蛋白。Protein A 通过结合抗体的 Fc 区和 B 细胞受体的 Fab 区，从而阻断调理吞噬作用并在体外导致 B 细胞凋亡 (apoptosis)。Protein A 可与 IgG 形成毒性免疫复合物，进而诱导白细胞坏死。Protein A 有助于金黄色葡萄球菌的毒力表达。Protein A 在经 IgG 预处理的小鼠模型中引发过敏反应。Protein A 可用于免疫系统疾病的相关的研究。
Hyaluronan-binding peptide, biotin labeled TFA 是一种有生物活性的肽。(该肽是一种通过 C 端 GGGSK 连接体生物素化的透明质酸结合肽。透明质酸 (HA) 是一种在细胞外基质和细胞表面表达的非硫酸化糖胺聚糖。 HA 在受精、胚胎发育、伤口愈合、血管生成、白细胞运输至发炎组织和癌症转移中发挥作用。该肽已被证明可以阻断 HA 与 CD44 受体的结合并抑制 T 细胞增殖。)
Hyaluronan-binding peptide, biotin labeled 是一种有生物活性的肽。(该肽是一种通过 C 端 GGGSK 连接体生物素化的透明质酸结合肽。透明质酸 (HA) 是一种在细胞外基质和细胞表面表达的非硫酸化糖胺聚糖。 HA 在受精、胚胎发育、伤口愈合、血管生成、白细胞运输至发炎组织和癌症转移中发挥作用。该肽已被证明可以阻断 HA 与 CD44 受体的结合并抑制 T 细胞增殖。)
Human CCR4 mRNA编码人类CC基序趋化因子受体4 (CCR4) 蛋白，该蛋白属于G蛋白偶联受体家族。CCR4是CC趋化因子（MIP-1、RANTES、TARC和MCP-1）的受体。趋化因子是一类结构相关的小分子多肽，能够调节各种白细胞的细胞运输。趋化因子还在免疫系统的发育、稳态和功能中发挥重要作用，并对中枢神经系统细胞以及参与血管生成或血管停滞的内皮细胞产生影响。
Your information is safe with us. * Required Fields.
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
MedchemExpress Validation 03
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
MedchemExpress Validation 04
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
